Summary
- Current Price
- As of today, AKTX price is $0.14, down -0.15% on
- Current Price All-Time High
- AKTX price is currently -99.99% below its historical high of $2,380.00 set on
- Market Cap
- AKTX current market cap is $5M, down -85.95% year-over-year
- PE Ratio
- AKTX PE ratio is unknown
- Revenue
- AKTX current annual revenue is $0.00, unchanged year-over-year
- Next Earnings
- The next earnings release for AKTX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Akari Therapeutics, Plc |
| Ticker | NASDAQ: AKTX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | akaritx.com |
| Employees | 8 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| $0.14 | ||
| Price, 1D Change | -0.15% | |
| $5M | ||
| - | ||
| - | ||
| 0.85 | ||
| $0 | ||
| Revenue, 1Y Change | 0.00% | |
| -$1.66 | ||
| EPS, 1Y Change | +18.93% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:20 | |
| Next Split | 1:40 | |
| Last Ticker Change | CLTX | |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.66 | ||
| EPS Estimate | -$0.33 | |
| EPS Est. Change | +80.09% | |
| $0.00 | ||
| Revenue Estimate | - | |
| Revenue Est. Change | - | |
| $0.14 | ||
| Price Target | - | $1.00 |
| Price Tgt. Change | - | +633.14% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.00 | -$2.04 | +48.88% | |
| -$3.40 | -$1.66 | +51.24% | |
| -$0.33 | N/A | +80.09% | |
| -$0.30 | N/A | +81.90% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| - | $0.00 | - | |
| - | $0.00 | - | |
| - | N/A | - | |
| - | N/A | - |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| -89.55% | ||
| -97.28% | ||
| -85.95% | ||
| -73.91% | ||
| 0.00% | ||
| 0.00% | ||
| +18.93% | ||
| +79.58% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| $0.14 | ||
| $0.65 | ||
| SMA 200 vs Price | +375.44% | |
| $0.23 | ||
| SMA 50 vs Price | +70.23% | |
| 0.85 | ||
| $0.03 | ||
| 26.72 | ||
| 156.52% | ||
| 103.06% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.66 | ||
| -$14.00K | ||
| - | ||
| -$16.65M | ||
| - | ||
| -$19.80M | ||
| - | ||
| -$19.53M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.15 | ||
| 0.15 | ||
| 0.15 | ||
| - | ||
| - | ||
| -8.41 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 0.21 | ||
| -0.34 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $22.23M | ||
| $2.66M | ||
| $50.66M | ||
| $2.95M | ||
| $28.43M | ||
| $19.91M | ||
| $3.26M | ||
| $3.26M | ||
| $0.00 |
Expenses
| Metric | Date | Value |
|---|---|---|
| $16.65M | ||
| $16.65M | ||
| $14.00K | ||
| $9.66M | ||
| $14.00K | ||
| $0.00 | ||
| $0.00 |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$12.55M | ||
| $382.00K | ||
| $10.99M | ||
| $0.00 | ||
| -$12.55M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Ladenburg Thalmann | ||
| HC Wainwright & Co. | → | |
| Maxim Group | ||
| HC Wainwright & Co. | ||
| Alliance Global Partners | ||
| B. Riley Securities | ||
| B. Riley FBR | ||
| B. Riley FBR | ||
| Canaccord Genuity | → | |
| B. Riley Securities |
Analyst sentiment
Institutional ownership
Screeners with AKTX
FAQ
What is the ticker symbol for Akari Therapeutics, Plc?
The ticker symbol for Akari Therapeutics, Plc is NASDAQ:AKTX
Does Akari Therapeutics, Plc pay dividends?
No, Akari Therapeutics, Plc does not pay dividends
What sector is Akari Therapeutics, Plc in?
Akari Therapeutics, Plc is in the Healthcare sector
What industry is Akari Therapeutics, Plc in?
Akari Therapeutics, Plc is in the Biotechnology industry
What country is Akari Therapeutics, Plc based in?
Akari Therapeutics, Plc is headquartered in United States
When did Akari Therapeutics, Plc go public?
Akari Therapeutics, Plc initial public offering (IPO) was on January 6, 2014
Is Akari Therapeutics, Plc in the S&P 500?
No, Akari Therapeutics, Plc is not included in the S&P 500 index
Is Akari Therapeutics, Plc in the NASDAQ 100?
No, Akari Therapeutics, Plc is not included in the NASDAQ 100 index
Is Akari Therapeutics, Plc in the Dow Jones?
No, Akari Therapeutics, Plc is not included in the Dow Jones index
When was Akari Therapeutics, Plc last earnings report?
Akari Therapeutics, Plc's most recent earnings report was on August 13, 2025
When does Akari Therapeutics, Plc report earnings?
The next expected earnings date for Akari Therapeutics, Plc is April 16, 2026
Data Sources & References
- AKTX Official Website www.akaritx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1541157/000095017025054278/0000950170-25-054278-index.htm
- AKTX Profile on Yahoo Finance finance.yahoo.com/quote/AKTX
- AKTX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/aktx